MMP14 and neoplasm: Importantly, its in vivo anti-tumor effect was associated with the disruption of immunosuppressive TME, including limiting tumor neoangiogenesis and hypoxia, suggesting that MMP-14 inhibitory antibody suppresses tumor progression and metastasis through its effect on TME in TNBC.